<DOC>
	<DOCNO>NCT03083158</DOCNO>
	<brief_summary>Infection cancer major cause death morbidity , may preventable vaccination . It fully understand molecular level people respond good others vaccine technology ass available . This impaired vaccine development . The overall goal Human Vaccines Project understand 'rules ' vaccine work . In demonstration project investigator vaccinate healthy adult hepatitis B vaccine start understand good work , ultimately help rational vaccine design future .</brief_summary>
	<brief_title>Immunity Hepatitis B Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adult , correspond one study age group . No history hepatitis B disease . No prior receipt hepatitis Bcontaining vaccine . Undetectable level antiHBs antiHBc antibody HBs antigen study enrolment ( indicate evidence prior hepatitis B vaccination infection ) . Generally good health ( stable chronic condition acceptable ) , live independently minimal assistance ( Clinical Frailty score 15 ) able attend clinic appointment . Willing able comply requirement protocol . Has give inform consent participation study . The participant may enter study ANY follow apply : Individual delegation log study History household contact know hepatitis Binfected individual . Planned administration vaccine specify study protocol 1 month pre 1 month post1st dose vaccine . Planned receipt investigational drug duration study . Confirmed suspect immunodeficiency . A family history congenital hereditary immunodeficiency . Receipt 1 week immunosuppressant immune modify drug ( e.g . oral prednisolone &gt; 0.5ml/kg/day intravenous glucocorticoid steroid ) 3 month prior dose 1 vaccine . Nasal , topical inhale steroid allow . Currently take antiplatelet anticoagulant medication ( include daily lowdose aspirin ) . Bleeding disorder thrombocytopenia , contraindicate IM injection , blood collection and/or lymph node fine needle aspiration . Administration immunoglobulin within prior 12 month and/or blood product within prior 3 month plan study period . Current pregnancy planning become pregnant 6 month postdose 1 vaccination . History allergy component vaccine . Unstable medical condition , indicate requirement hospitalization substantial medication change stabilize say condition within previous 3 month . History neurologic disorder seizure , include history GuillainBarre syndrome . Clinical Frailty score 67 ( moderately frail severely frail ) . Scheduled elective surgery procedure require general anaesthesia 1 month pre 1 month post1st dose vaccine . Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study . Temporary exclusion acute symptomatic illness 7 day prior plan first vaccine dose vaccination delay , participant remain study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>